Navigation Links
Bertil Fredholm wins the 2011 ECNP Neuropsychopharmacology Award in basic science research
Date:4/19/2011

The European College of Neuropsychopharmacology (ECNP) is pleased to announce Bertil Fredholm as the recipient of the 2011 ECNP Neuropsychopharmacology Award in Basic Science Research in recognition of his pioneering work on the brain adenosine system. The ECNP Neuropsychopharmacology Award is presented annually and recognises distinguished research in neuropsychopharmacology and closely related disciplines. The award is accompanied by a prize of 20,000.

Bertil Fredholm, professor of pharmacology at the Karolinska Institutet, Sweden, has built an outstanding body of work over a highly distinguished career. His pioneering research on adenosine and its receptors has not only significantly advanced the understanding of physiological and pathophysiological CNS mechanisms, but has provided new targets for drug development across a range of brain disorders.

After his PhD training focusing on the sympathetic nervous system and transmitter regulation, Fredholm turned to adenosine. Motivated by his early realisation that the most widely used psychoactive drug caffeine acts by blocking actions of adenosine on its receptors, he began by attempting to identify the factor released by nerve stimulation in intact tissues that regulated transmitter release, transmitter actions and circulation. Having identified adenosine as the likely candidate, he was able to document how its release from effector cells responded to nerve activity or reduced circulation and how adenosine could traverse the synapse to act presynaptically to limit transmitter release in several tissues. Fredholm has documented the generality of this concept in a series of highly influential papers and review articles.

With a body of work that now spans more than 30 years and a range of techniques to his credit, Fredholm is today one of the world leaders in this highly active and important field, and the hub of a worldwide research network.

Speaking on behalf of the ECNP Award Committee, Julien Mendlewicz, Belgium, said, "Bertil Fredholm's leadership in the field and outstanding research achievements, based on broad knowledge and outstanding scientific intelligence, make him the ideal candidate for this award."

The award will be presented at the 24th ECNP Congress on 3-7 September 2011 in Paris, France, where Professor Fredholm will also deliver the prize-winner's plenary lecture.


'/>"/>

Contact: Ligia Bohn
l.bohn@ecnp.eu
31-302-538-567
European College of Neuropsychopharmacology
Source:Eurekalert

Related medicine news :

1. Top Swedish scientist professor Bertil Andersson awarded prestigious Wilhelm Exner Medal in Vienna
2. Mental Health America Encourages Journalists, Media Professionals to Submit Entries for 2010 Media Awards
3. 2010 HSR Impact Award recognizes surgical safety research
4. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
5. International Diabetes Federation awards $2 million to 9 global diabetes research projects
6. Highmark Foundation Awards $120,000 to the American Heart Association
7. Rocketboy Media Wins Award for Masonic Lodge Web Site; Announces Signing of Several New Clients
8. Multi-Award Winning Author Tina Turbin Interviews Special Guest Dr. Peter H.R. Green, M.D. On The Thrive in Balance Radio Show
9. Gladstones Robert Mahley to receive Research!America advocacy award
10. Republicans Give Top Award to Betsy McCaughey, Healthcare Patriot, & Rev Up for Upcoming Elections
11. Diane von Furstenberg Establishes The DVF Awards to Recognize Outstanding Women Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges the ... how his administration could impact the employee benefits industry. James Slotnick, AVP, Government ... likely to make it through Congress. His discussion will focus on the current ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... Minneapolis MN (PRWEB) , ... April 25, 2017 , ... ... patients and recreational users to dispensaries and head shops –can’t help but be heartened ... loathing for the tell-tale cannabis odor aptly described as “skunk smell.” At last ...
(Date:4/25/2017)... Hollywood, Fl (PRWEB) , ... April 25, 2017 , ... ... than Memorial Regional Hospital, according to a special report in the May issue of ... Hospital its highest quality ranking for results achieved during and after coronary bypass ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS ... Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. ... pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: